- Drug Pipelines
- January 2022
- 30 Pages
Global
From €455EUR$500USD£390GBP
Metgluco is a type of gastrointestinal drug used to treat diabetes. It is a combination of metformin and glibenclamide, two drugs used to control blood sugar levels. Metgluco is used to treat type 2 diabetes, a condition in which the body does not produce enough insulin or does not use insulin properly. It works by increasing the body's sensitivity to insulin and decreasing the amount of glucose produced by the liver. Metgluco is usually taken once or twice a day with meals.
Metgluco is a popular drug in the gastrointestinal market, as it is effective in controlling blood sugar levels and is relatively safe. It is also relatively inexpensive compared to other diabetes medications.
Some companies in the Metgluco market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. Show Less Read more